Search results

The IAEA is providing $1.3m over four years to implement a new, Australian-led patient-care project for the Asia and Pacific region

Meeting of minds about potential next-generation cancer treatment for Australians

Neutron Capture Enhanced Particle Therapy developed at ANSTO.

See details of previously published customer updates from our Health products team. 

Australia’s new state-of-the-art nuclear medicine facility gets green light.

Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .

Early research at ANSTO has contributed to development of innovative submicron particle encapsulation technology.

A large team of ANSTO scientists in collaboration with University of Wollongong researchers has developed a new hybrid technique that enhances the effectiveness of a cutting-edge form of radiation therapy for advanced cancer.

Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.

Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia

Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.

The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.

ANSTO is dedicated to identifying opportunities for the application of knowledge and technology developed by the organisation for a wide range of industry applications.

Melbourne researchers map the structure of a key COVID-19 protein using the Australian Synchrotron

Developed by ANSTO’s predecessor the Australian Atomic Energy Commission (known as the AAEC) in the late 1960s, the Technetium-99m Generator revolutionised nuclear medicine imaging in Australia by enabling imaging procedures to be performed not only in major capital cities but throughout regional and rural Australia.